Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
confidence in SVFC should grow as the news starts to sink in about the IR decision in SVFC's favor!!! I believe we now start to move up!!!
I completely agree!!! we can be sure that SVFC has prevailed! the only thing in question now is how much monetary damage SVFC will receive. IT COULD BE HUGE!!!!$$$$$
I'm guessing things are about to start going in the other direction. UP up up it will go and where it will stop nobody knows!!!
Extremely undervalued is undeniably an understatement and some are unaware or don't understand the unrealized gains and untapped potential under these oversold conditions
Just a thought that came to me. Maybe the judge or IR stopped the YA deal? I can picture a scenario where IR would ask the judge to stop any further funding agreements until the case is settled. Or a scenario where the judge without being asked would prevent any further funding until the case is settled. I guess we will find out soon.
but you do have to agree that has been priced in, correct?
you mean like these?
idiot75783 Sunday, 05/04/14 02:05:41 PM
Re: Toeinmouth post# 65037
Post # of 65046
With no realistic plans to turn the 50 mil patent into revenue SVFC is worth $0.
It may seem like we are stuck in limbo. But let me ask you this, do you think that we will never get another pr from SVFC? Of course not! And do you think the next pr we get From SVFC Will be positive? More than likely! So my next question is why would anyone sell knowing we are going to get a positive pr? The answer to this question is short so short in fact I won't even say it.
I seriously doubt that your assessment of SVFC is even remotely possible . An argument that states "all the good news is priced into SVFC" would mean that when SVFC releases a pr about the final judgment against IR the price would not go up. And when SVFC releases it's 10k with revenues the price will not go up. Or when the pr is released about YA Global's loan to SVFC is not in default the price would not go up. Or maybe the next pr will state that a new contract worth 10 million dollars annually has been signed and the pps will not go up. And when the international patents are granted the pps will not go up. Or when SVFC releases a pr about a government grant worth millions of dollars the price won't go up. And I could go on and on. So how can you say all the good news is priced into Svfc??? The fact is that SVFC is extremely under valued and the next pr that we get will more than likely be good news and the pps will go up! Have a great day! :)
5.62 million dollar market cap??? Are you fricken kidding me? With this low of a market cap ALL of the doom and gloom scenarios must be priced in to the stock!!! And then some!!! The Doctor could sell the US patent alone for 50 million dollars pay off all debt including YA and all the shareholders and still have enough money left over to buy a nice Yacht!!!
SVFC is so ridiculously under valued !!!!!
Fight or flight / stay long or sell
Fear has a funny way of making us believe in the worst case scenario!! The reasons for this are many, but the strongest one is " fight or flight" this is a stress induced release of hormones meant to prepare us to fight or to flee. I'm sure that every has experienced a time in their life where, somebody they loved was late and not answering their phone (the 10k) and thoughts of tragedy start running through your head, soon you have convinced yourself that only the worst cast scenario could be possible. But as things would turn out, every thing is fine and there was a very good explanation. The stress caused by the situation triggered the fight or flight response preparing you for the worst case scenario. The problem with the flight or flight response is that smart investors can use this against you! It causes one to react quickly and not rationally! So before you sell ask yourself if you are selling based on sound investment strategy or fear???
WRONG!!!
Dr. Steven Victor, founder and CEO of IntelliCell
"I will be converting a portion of my debt into shares and will continue this practice going forward."
Beautiful sticky!!!
You might want to raise your bid, have you noticed how the pps always seems to somehow make it back to at least .004 the last second of the day? Do you think that is some guy painting the pps with 10k shares $40 bucks? Or maybe the mm's are making sure the pps doesn't close below .004 because of the reasons I stated?? I wish you the best and if you are happy with the amount of shares you have and are just trying to avg down then I say go for it . But if you want more shares I think you may need to be at .0039
Good luck
I don't think we go any lower!!! "Somebody" has been driving the pps down so they can pick up shares. We wont go any lower because if we do then major panic selling will set in and that "somebody" that has been buying all the shares in the low .004's and high .003's will stand to loose a lot of money!!! Big forces at play with this one!!! and huge manipulation of the pps!! It's BS!!!! like a damn politician breaking the law with no consequences!! But.... What can I do? They are driving the car and if I want a ride I will have to wait until they are ready to leave.
IT'S BS !!!!!
I hope that you really think that!!! And I hope that you invest accordingly!!!!! Nothing would make me happier than for SVFC to have a major break out and a major short squeeze causing financial devastation to those on the wrong side of the move!!!!!!!
Agreed!!!
doesn't seem fair
Lol :). I got so confused trying to figure out if I was supposed expect it or not:) I still can't wrap my head around it ¿
I believe we are already taking off! Just look at the resent pr's !!! This is not child's play!!! The only thing wrong with SVFC is that the pps is way too low!!!! But that is about to be corrected. Copper first then silver then the ALMIGHTY DOLLAR!!!!!
I'm sure there is a great reason also, I just wish they would share their secret with us!! I have faith and I'm not going anywhere for a long time! My stop loss is a very long way from here and my stop profit is so far away I can't even count that high!!! And I can count pretty high
The email is sent is real !! And I will post the real reply when I get one. However with all the emails that SVFC is probably getting I would expect they will reply via a pr. Either way I don't think we will have to wait much longer.
This is the response I received.
dear, #### ######## thank you for your inquiry. We are pleased to inform you that the only thing you need to be concerned about is how you are going to spend all the damn money you will make with SVFC!!!
LOL :)
But it's probably true!!!!!
I just sent an email.
I will post the response when I receive it.
dear, IntelliCel BioSciences Inc. I hold a large position in SVFC and have been a shareholder for almost a year. I am very impressed with all recent press releases! It sounds like you have been very busy and I wish SVFC the very best! I am however becoming increasingly concerned with a coup[le of issues. i.e. the IR court case, the YA funding and the late filling of the 10k. I would very much appreciate it if you could please update the shareholders with any information allowed. perhaps a shareholder letter would be helpful to calm nerves.
Thank you very much for your time and all the hard work you are doing for shareholders and indeed the world!!!
SVFC $$$ Roche Laboratories $$$
The former president of multi-billion dollar Biotech Roche Laboratories - Myron Holubiak - is now with SVFC!!!!
Myron Holubiak, Director, Chair of the Nominating and Governance Committee
Myron Holubiak is currently President of 1-800-Doctors, Inc. Mr. Holubiak is also Chairman of the Board of Directors of BioScrip, Inc., an infusion and home health company, and Lead Independent Director of Ventrus BioSciences, Inc. From 1998 through 2001, Mr. Holubiak was President of Roche Laboratories, Inc. and previously in his career, he co-founded and served as CEO to Emron, Inc, a strategic marketing firm serving the pharmaceutical industry, which was acquired by Dunn & Bradstreet and IMS Health in 1995. Mr. Holubiak also currently serves on the Board of Trustees for the Academy of Managed Care Foundation.
http://www.intellicellbiosciences.com/corporate-profile.html
SVFC has the #1 Stem Cell Technology In THE WORLD!!
IntelliCell BioSciences' Stem Cell Technology Validated by Merck Subsidiary
NEW YORK, NY--(Jul 14, 2011 07:00 ET) - IntelliCell BioSciences, Inc. (OTCQB: SVFC) (PINKSHEETS: SVFC) ("IntelliCell" or the "Company"), a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) containing adipose derived adult stem cells, today announced that an antibody flow cytometry study of IntelliCell's technology was performed by Millipore, a division of Merck, a life science leader providing cutting-edge technologies, tools and services for bioscience research and biopharmaceutical manufacturing.
The results of the study conclude that IntelliCells? manufactured by IntelliCell's proprietary technology yield an average of 10 times (10X) the number of SVF cells containing adult adipose stem cells from less fat (only 2 oz) than that which the Company believes is used by any of its present competition utilizing enzymes in their process. The study also showed that IntelliCells? contain all of the viable cells that are manufactured by competing technologies that use enzymatic digestion.
"We believe IntelliCell is setting the gold standard for adipose stem cell processing without the use of enzymes and yielding high number of SVFs with adult adipose stem cell counts. We feel that our technology is a true game changer in the field of regenerative medicine and that SVF could show incredible promise for a wide range of clinical uses in the near future," stated IntelliCell Chairman and CEO, Dr. Steven Victor.
"We believe that the body stores all of the reparative and regenerative cells it could possibly need as a result of trauma or illness in the stromal vascular fraction (SVF) contained in the fat. We are very pleased with the results of Millipore's study as it does confirm that at least four of these pluripotent stem cell types are indeed existent in this tissue, and our technology has, for the very first time in history, unlocked these cells which have similar potential to embryonic stem cells in their pluripotency, in vast number, from a source that entails no moral controversy, and no chemical additives required for digestion of the tissue -- requiring only minimal, mechanical manipulation of the tissue as defined by the FDA's rule 361," concluded Dr. Steven Victor.
The use of autologous adipose (fat) stem cells has become a new and exciting frontier in medicine. Numerous doctors, companies and researchers are studying the use of these adipose stem cells for applications that include the treatment of arthritis and numerous orthopedic injuries such as knees, elbows and shoulders; wound healing; back pain; congestive heart failure; gum recession; and fat augmentation for breast, buttock and face; as well as other disease states.
In the aesthetic world, the use of autologous adipose stem cells has become widely accepted in Europe and Asia. Since the middle of 2009 when the US FDA published its laws on autologous stem cells the field has expanded rapidly.
IntelliCell has developed an in-house technology where it can easily process stromal vascular cells containing a high concentration of adipose stem cells with excellent viability. At present, management believes it is the only company that does not use enzymes in processing adipose tissue and actually counts and checks the adipose stem cells they manufacture.
The adipose stem cell processing technique of IntelliCell takes approximately 30 minutes and the stem cells can be returned to the doctor in the same day. Autologous Adipose Stem Cells are on the cutting edge of medicine and IntelliCell is excited to be one of the premier companies to participate in this field.
http://www.intellicellbiosciences.com/intellicell-biosciences-stem-cell-technology-validated-by-merck-subsidiary.html
Dr. Steven Victor, founder and CEO of IntelliCell
"I will be converting a portion of my debt into shares and will continue this practice going forward."
IntelliCell's Chief Executive Officer, Dr. Victor, remarked, "This is wonderful news in that we are expanding our international patent portfolio to further protect our patent around the world. And I believe that we are now in the phase of our international patent process to reach out and seek international partners to whom we would license our technology and cellular labs and start generating international revenues."
http://ih.advfn.com/p.php?pid=nmona&article=61697331
IntelliCell BioSciences Has Received Its Hong Kong Patent Application Notice for ULTRASONIC CAVITATION
Date : 04/02/2014 @ 11:57AM
Source : Marketwired
Stock : Intellicell Biosciences, Inc. (PL) (SVFC)
Quote : 0.0041 0.0 (0.00%) @ 4:37PM
IntelliCell BioSciences Has Received Its Hong Kong Patent Application Notice for ULTRASONIC CAVITATION
Intellicell Biosciences, Inc. (PL) (USOTC:SVFC)
Historical Stock Chart
1 Month : From Apr 2014 to May 2014
Click Here for more Intellicell Biosciences, Inc. (PL) Charts. IntelliCell BioSciences Has Received Its Hong Kong Patent Application Notice for ULTRASONIC CAVITATION
NEW YORK, NY--(Marketwired - Apr 2, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular fraction cells (SVFCs) derived from the blood vessels found in adipose tissue, has received notice of publication for its technology patent in Hong Kong for ULTRASONIC CAVITATION DERIVED STROMAL OR MESENCHYMAL VASCULAR EXTRACTS AND CELLS DERIVED THEREFROM OBTAINED FROM ADIPOSE TISSUE AND USE THEREOF.
HK Patent Application No 13113908.9
IntelliCell's Chief Executive Officer, Dr. Victor, remarked, "This is wonderful news in that we are expanding our international patent portfolio to further protect our patent around the world. And I believe that we are now in the phase of our international patent process to reach out and seek international partners to whom we would license our technology and cellular labs and start generating international revenues."
About IntelliCell Biosciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell BioSciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell will also be seeking to develop technology-licensing agreements with technology developers, universities, and international business entities.
Forward-Looking Statements
Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
IntelliCell BioSciences, Inc.
Investor Relations
Anna Rhodes
Email Contact
(646
http://ih.advfn.com/p.php?pid=nmona&article=61697331
Notice it says "shareholder" not "shareflipper" or "shareshorter"
LATEST SHAREHOLDER LETTER
NEW YORK, NY--(Marketwired - Dec 10, 2013) - IntelliCell Biosciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, provides shareholder update.
Dear Valued Shareholders,
On behalf of myself, the Board of Directors and the entire IntelliCell team, I would like to let you know that we are pleased with the growth initiatives that we have accomplished since our initial shareholder letter.
Now is an important and exciting time for IntelliCell Biosciences. We have continued to improve our competitive position in the regenerative medicine field and I believe we have never been stronger or better positioned for future growth. The worldwide regenerative medicine market is being driven by previously unseen treatments and procedures that are improving the quality of life of patients around the world and we firmly believe that we will emerge as one of the leaders in this industry.
The Company has been executing on our strategic plan and business priorities this year. We have made advancements in our technology and have filed patents around the world for our proprietary regenerative medical solutions. I am encouraged by the expanding market presence of IntelliCell Biosciences and the escalating acceptance of the Company's products and solutions within the medical, scientific and investment community. Additionally, we continue to work hard at improving our balance sheet and financial position, in order to have the necessary resources to take advantage of our growth opportunities. Because of all these accomplishments, I believe we are better positioned than ever for growth.
We have focused primarily on three strategic initiatives, Growth, Leverage, and Financial Strength, in order to improve the overall standing of the company.
Growth: We will continue to grow and supply our cellular product to physicians to treat their patients with clinical needs. We intend to be a major provider of minimally manipulated stromal vascular fraction cells SVFCs for autologous use to physicians and achieve exciting clinical results that improve the quality of life for their patients.
Leverage: We are leveraging our scale and best practices to create a cost-effect business model that increases our competitive advantage over our industry peers. Our intent is to open 3 additional facilities in 3 states in the next 12 months. Once the model is perfected, we will roll out additional facilities at a more aggressive pace. As the regenerative medical market expands, we intend to be the most recognized name in the industry.
Financial Strength: We have a goal of improving our balance sheet and income statement in order to deliver strong shareholder returns. Currently we are enacting a plan to remove all debt from our balance sheet. Going forward, it is our intent to use equity capital for the advancement of our company. Believing that IntelliCell Biosciences stock is undervalued, I will be converting a portion of my debt into shares and will continue this practice going forward. These measures will enable us to continue implementing our business and open new Cellular Labs in hospitals and ambulatory surgical centers that will significantly increase our revenues.
We are committed to advance the regenerative medicine field. This will enable us to become more productive, reliable and cost effective than ever before. IntelliCell's physician partners have informed us that we are well-aligned with their strategic intentions, and their clinical and business priorities. These are the key priorities that will ensure IntelliCell's future success.
As many of you know, our technology is new and cutting edge and requires acceptance by the marketplace and the regulators. We will remain aggressive in our efforts to overcome industry obstacles so that our medical solutions can serve as the industry standard. The Company has successfully developed advanced medical technologies, most notably its patented process of isolating SVFCs from adipose (fat) tissue using a mechanical technique, exclusive to the industry of regenerative medicine, now being used by physicians to treat patients with previously unmet clinical needs.
Management firmly believes that regenerative medicine is the future of medicine and we intend to aggressively expand our market footprint in order to solidify our position as the leader in the field. We would like to express our gratitude to our loyal global customer base and we are grateful to our shareholders for their continued support and ownership in our company. As CEO and Founder of IntelliCell, my paramount responsibility is to enhance shareholder value. I take immense pride in the success of this company to date and remain committed to delivering the best products and services possible to increase market presence in the future.
We at IntelliCell Biosciences are confident that our vision and goals will be achieved.
Sincerely,
Dr. Steven Victor
Chief Executive Officer
IntelliCell Biosciences
The resent pr's show that SVFC is moving ahead with it objectives "to be a world leader in regenerative medicine" sooner or later the pps will explode!!!!
In my opinion.... Big money holding this down. But hang on because when the tide changes we will fly!!!!!
Soon People will refer to a stock that goes parabolic as " going SVFC" it will be a common saying like "going postal" lol :)
Yes!!! It is all adding up!!! I can't remember EVER seeing another otc stock with so much potential !!! Just a couple of speed bumps and then it's full speed ahead for SVFC!!!!!!!
You are so right!!! What a great opportunity to load!!! I would love to buy more but I am all in with 12.6 million:) do you know hard it is to see the pps so low and not be able to buy more;( oh well, I am still in the green and buying more would mean I would have to average up ( witch I would love to do) but it is what it is and all I can do now is wait and wait and wait witch is getting older and older and older. But the longer We wait the the closer we get to the prize!!!!
Anything worth having is worth waiting for!!!
If making money in penny stocks was an easy, low risk and high reward venture we would all be very rich! It's not easy and there is plenty of risk but those that are fortunate enough to find and stick with a company with a major disruptive technology have the opportunity to make a fortune!!! I believe SVFC is that company!!! We will have ups and downs but we will get there!!! No risk no reward!!!
Go SVFC
Anybody know what day it is???? HUMP DAY!! We are over the hump and tomorrow is MAY 1st Statistics show May dollar volume is nearly 4X that of April. So I would venture to say things will start to pick up considerably !!
http://www.otcbb.com/dynamic/tradingdata/sharedollarvolume/dollar.htm
I'm a shareholder and I'm not concerned